CG
SBIO icon

Colony Group’s ALPS Medical Breakthroughs ETF SBIO Stock Holding History

Colony Group’s Portfolio SBIO Stock Details SBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q1 		– Sell
-200
Closed -$6K – 559
2015
Q4 		$6K Buy
+200
New +$6.13K ﹤0.01% 643

Other funds holding SBIO

Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return
Commonwealth Equity Services
Commonwealth Equity Services Waltham, Massachusetts $71.6B AUM 21.08% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
VKH
Virtu KCG Holdings New York $3.6B AUM 17.11% 1-Year Est. Return
RJA
Raymond James & Associates St Petersburg, Florida $164B AUM 33.91% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Colony Group's SBIO Position: Q1 2016 in Review

Colony Group sold out of ALPS Medical Breakthroughs ETF (SBIO) in Q1 2016, closing a stake of 200 shares — an estimated $6K sold.

Colony Group first reported a position in SBIO in Q4 2015 and held it in 1 quarter. The position peaked at $6K in Q4 2015. 23 funds tracked by Wall St. Rank hold SBIO as of Q1 2016.

  • Colony Group reported no remaining ALPS Medical Breakthroughs ETF position as of Q1 2016 after selling out during the quarter.
  • Colony Group sold 200 ALPS Medical Breakthroughs ETF shares in Q1 2016, an estimated $6K.
  • Colony Group first reported a position in ALPS Medical Breakthroughs ETF in Q4 2015 and held it in 1 quarter.
  • Colony Group's ALPS Medical Breakthroughs ETF position peaked at $6K in Q4 2015.
  • 23 funds tracked by Wall St. Rank held ALPS Medical Breakthroughs ETF as of Q1 2016.

Based on Colony Group's 13F filing for Q1 2016, filed 16 May 2016.